Filter
355
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
38
New Publications
110
Language
Document type
No document type
184
Guidelines
60
Studies & Reports
45
Strategic & Response Plan
27
Manuals
23
Training Material
6
Fact sheets
6
Situation Updates
3
Infographics
1
Countries / Regions
Kenya
19
Uganda
15
Global
15
India
14
Ghana
13
Western and Central Europe
13
Nigeria
12
Eastern Europe
11
Namibia
10
Nepal
9
South Africa
9
Ethiopia
8
Rwanda
8
Sierra Leone
6
Malawi
6
Zambia
5
Tanzania
5
South–East Asia Region
5
Liberia
4
Congo, Democratic Republic of
4
Cambodia
4
Bangladesh
4
West and Central Africa
4
Zimbabwe
3
Lesotho
3
East and Southern Africa
3
Latin America and the Carribbean
3
Russia
3
Senegal
2
Philippines
2
Syria
2
Indonesia
2
Mozambique
2
Sudan
2
Benin
2
Eswatini/ Swaziland
2
Ukraine
2
Botswana
2
Madagascar
2
Myanmar / Burma
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Cameroon
1
Haiti
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Gambia
1
Central African Republic
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Laos
1
Georgia
1
Vietnam
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
174
Clinical Guidelines
42
Public Health
9
Women & Child Health
6
Capacity Building
5
Key Resources
5
Pharmacy & Technologies
5
Toolboxes
TB
43
Pharmacy
37
AMR
29
Malaria
25
COVID-19
22
HIV
18
NTDs
16
NCDs
5
Ebola & Marburg
3
Refugee
2
Specific Hazards
2
Caregiver
2
Cholera
1
Polio
1
Rapid Response
1
Global Health Education
1
Planetary Health
1
2.0 Rapid Response
1
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra
...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of
...
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care;
...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
